Transactivation of the insulin-like growth factor-I receptor by angiotensin II mediates downstream signaling from the angiotensin II type 1 receptor to phosphatidylinositol 3-kinase.
D000804:Angiotensin II / Q000494:pharmacology / Q000502:physiology*; D000818:Animals; D000906:Antibodies / Q000494:pharmacology; D002465:Cell Movement / Q000187:drug effects / Q000502:physiology; D002478:Cells, Cultured; D004789:Enzyme Activation / Q000187:drug effects; D004791:Enzyme Inhibitors / Q000494:pharmacology; D007334:Insulin-Like Growth Factor I / Q000276:immunology; D020928:Mitogen-Activated Protein Kinases / Q000378:metabolism; D032389:Myocytes, Smooth Muscle / Q000502:physiology; D019869:Phosphatidylinositol 3-Kinases / Q000378:metabolism*; D010766:Phosphorylation / Q000187:drug effects; D011505:Protein-Tyrosine Kinases / Q000037:antagonists & inhibitors; D044140:Receptor, Angiotensin, Type 1 / Q000378:metabolism*; D017526:Receptor, IGF Type 1 / Q000187:drug effects / Q000235:genetics* / Q000378:metabolism; D015398:Signal Transduction / Q000502:physiology*; D013552:Swine; D015533:Transcriptional Activation / Q000502:physiology*; D019061:src-Family Kinases / Q000378:metabolism
D000906:Antibodies; D004791:Enzyme Inhibitors; D044140:Receptor, Angiotensin, Type 1; D000804:Angiotensin II; D007334:Insulin-Like Growth Factor I; D019869:Phosphatidylinositol 3-Kinases; D011505:Protein-Tyrosine Kinases; D017526:Receptor, IGF Type 1; D019061:src-Family Kinases; D020928:Mitogen-Activated Protein Kinases